Medicine & Life Sciences
Acinetobacter
34%
Anti-Bacterial Agents
83%
Antimicrobial Stewardship
27%
Artificial Respiration
37%
B7-H1 Antigen
28%
Bacteremia
27%
Bronchoalveolar Lavage
19%
Candidemia
24%
Cefepime
26%
Clinical Decision Rules
26%
Cohort Studies
30%
Confidence Intervals
21%
Coronavirus
26%
Critical Care
22%
Critical Illness
81%
Decision Making
29%
Epidemiology
24%
Gram-Negative Bacteria
34%
Gram-Positive Bacteria
23%
Healthcare-Associated Pneumonia
29%
Heart
16%
Hospital Mortality
22%
Hospital Rapid Response Team
28%
Human Influenza
16%
Immunocompromised Host
21%
Infections
87%
Intensive Care Units
59%
Lung
58%
Meropenem
24%
Methicillin-Resistant Staphylococcus aureus
58%
Microbial Drug Resistance
29%
Mortality
53%
Multiple Drug Resistance
20%
Numbers Needed To Treat
22%
Odds Ratio
22%
Pneumonia
32%
Pseudomonas
22%
Retrospective Studies
17%
Sepsis
63%
Septic Shock
100%
Skilled Nursing Facilities
25%
Smoke
17%
Soft Tissue Infections
24%
Tazobactam Drug Combination Piperacillin
23%
Terminal Care
23%
Therapeutics
27%
Tobacco Products
17%
Transplant Recipients
56%
Vancomycin-Resistant Enterococci
17%
Ventilator-Associated Pneumonia
69%